Management of Pediatric Severe Traumatic Brain Injury: 2019 Consensus and Guidelines-Based Algorithm for First and Second Tier Therapies.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 5 3 2019
pubmed: 5 3 2019
medline: 6 5 2020
Statut: ppublish

Résumé

To produce a treatment algorithm for the ICU management of infants, children, and adolescents with severe traumatic brain injury. Studies included in the 2019 Guidelines for the Management of Pediatric Severe Traumatic Brain Injury (Glasgow Coma Scale score ≤ 8), consensus when evidence was insufficient to formulate a fully evidence-based approach, and selected protocols from included studies. Baseline care germane to all pediatric patients with severe traumatic brain injury along with two tiers of therapy were formulated. An approach to emergent management of the crisis scenario of cerebral herniation was also included. The first tier of therapy focuses on three therapeutic targets, namely preventing and/or treating intracranial hypertension, optimizing cerebral perfusion pressure, and optimizing partial pressure of brain tissue oxygen (when monitored). The second tier of therapy focuses on decompressive craniectomy surgery, barbiturate infusion, late application of hypothermia, induced hyperventilation, and hyperosmolar therapies. This article provides an algorithm of clinical practice for the bedside practitioner based on the available evidence, treatment protocols described in the articles included in the 2019 guidelines, and consensus that reflects a logical approach to mitigate intracranial hypertension, optimize cerebral perfusion, and improve outcomes in the setting of pediatric severe traumatic brain injury.

Identifiants

pubmed: 30830015
doi: 10.1097/PCC.0000000000001737
pii: 00130478-201903000-00008
doi:

Substances chimiques

Barbiturates 0
barbituric acid WQ92Y2793G

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

269-279

Auteurs

Patrick M Kochanek (PM)

Department of Critical Care Medicine, Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.

Robert C Tasker (RC)

Department of Neurology and Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA.
Harvard Medical School, Boston, MA.

Michael J Bell (MJ)

Critical Care Medicine, Children's National Medical Center, Washington, DC.

P David Adelson (PD)

Pediatric Neurosurgery, BARROW Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ.

Nancy Carney (N)

Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.

Monica S Vavilala (MS)

Harborview Injury Prevention and Research Center (HIPRC), University of Washington, Seattle, WA.

Nathan R Selden (NR)

Department of Neurological Surgery, Oregon Health & Science University, Portland, OR.

Susan L Bratton (SL)

University of Utah, Salt Lake City, UT.

Gerald A Grant (GA)

Department of Neurosurgery, Stanford University, Stanford, CA.

Niranjan Kissoon (N)

Department of Pediatrics, British Columbia's Children's Hospital, Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada.

Karin E Reuter-Rice (KE)

School of Nursing/School of Medicine, Department of Pediatrics, Division of Pediatric Critical Care Medicine, Duke University, Durham, NC.

Mark S Wainwright (MS)

Division of Pediatric Neurology, University of Washington, Seattle Children's Hospital, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH